Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.
1 other identifier
observational
276
1 country
5
Brief Summary
This study aims to determine the effectiveness of the different programmes of four Spanish hospitals about prevention of axillary lymphadenectomy sequels in breast cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 27, 2017
CompletedFirst Submitted
Initial submission to the registry
September 28, 2017
CompletedFirst Posted
Study publicly available on registry
October 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedFebruary 23, 2018
February 1, 2018
3 months
September 28, 2017
February 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
breast cancer-related lymphedema
Truncated cone formula
The agreed date with the participant for the evaluation (second half of 2017)
Secondary Outcomes (2)
functional shoulder limitation
The agreed date with the participant for the evaluation (second half of 2017)
Symptoms associated with breast cancer-related lymphedema
The agreed date with the participant for the evaluation (second half of 2017)
Other Outcomes (1)
Degree of compliance with the prevention program
The agreed date with the participant for the evaluation (second half of 2017)
Study Arms (4)
axillary lymphadenectomy sequels
Patients who have suffered from axillary lymphadenectomy due to breast cancer between 2014 and 2016 and who have developed breast cancer-related lymphedema and/or shoulder disability who fulfill or not a preventive programme
No axillary lymphadenectomy sequels
Patients who have suffered from axillary lymphadenectomy due to breast cancer between 2014 and 2016 and who have not develped breast cancer-related lymphedema and/or shoulder disability who fulfill or not a preventive programme.
Fulfillment of a preventive programme
Patients who fulfil a preventive programme for axillary lymphadenectomy sequels
No fulfillment of a preventive programme
Patients who do not fulfil a preventive programme for axillary lymphadenectomy sequels
Interventions
Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
No fulfillment of the preventive programme: Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
Eligibility Criteria
Women suffering from axillary lymphadenectomy due to breast cancer in four spanish hospitals
You may qualify if:
- Suffering from axillary lymphadenectomy due to breast cancer treatment between 1 january 2014 until 31 december 2016.
You may not qualify if:
- Lymphedema prior to surgery in any of the upper limbs or any malformation or injury that prevents comparison of both upper limb volumes.
- Cognitive impairment or intellectual disability that would prevent understanding the instructions of the study, as well as the purpose of the same.
- Serious condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Violeta Pajero Oterolead
- Hospital Universitario 12 de Octubrecollaborator
- University of Castilla-La Manchacollaborator
- Puerta de Hierro University Hospitalcollaborator
- Complejo Hospitalario Universitario de Cartagenacollaborator
Study Sites (5)
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
Complejo Hospitalario Universitario de Cartagena
Cartagena, Murcia, 30203, Spain
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
Castilla-La Mancha University
Toledo, 45071, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Violeta Pajero Otero, MRes
Hospital Universitario 12 de Octubre
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Physiotherapist at the Mammary Pathology Unit
Study Record Dates
First Submitted
September 28, 2017
First Posted
October 3, 2017
Study Start
September 27, 2017
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
February 23, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share